Release Date: 24/11/10 09:48 Summary: Operations recommence at Triple Crown Prospect Price Sensitive: Yes Download Document 81.48KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling